First Circuit Debates Drug ‘Pay for Delay’ Class

, The National Law Journal

   | 0 Comments

A federal appeals court on Thursday probed a Boston federal judge’s certification of an antitrust class action challenging AstraZeneca PLC’s "pay for delay" settlements with three generic drug makers.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202665449749

Thank you!

This article's comments will be reviewed.